Gemfields Group Limited (GML.JO)
ZAc 167.0
(7.74%)
ZAc 167.0
(7.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 35.23 Million | 119.49 Million | 98.12 Million | -20.16 Million | 36.68 Million | 5.1 Million |
| Net Income | 16.56 Million | 114.65 Million | 104.42 Million | -99.2 Million | 67.37 Million | -53.94 Million |
| Depreciation & Amortization | 36.93 Million | 37.67 Million | 27.53 Million | 21.02 Million | 34.82 Million | 30.63 Million |
| Deferred income taxes | -26.22 Million | - | -12.92 Million | 26.4 Million | -43.46 Million | 44.78 Million |
| Stock-based compensation | 96 Thousand | 150 Thousand | 367 Thousand | 944 Thousand | 1.69 Million | 4.16 Million |
| Change in working capital | 7.04 Million | -7.47 Million | -24.72 Million | 24.87 Million | -28.19 Million | -29.32 Million |
| Other non-cash items | 818 Thousand | -25.49 Million | 3.44 Million | 5.78 Million | 4.46 Million | 8.79 Million |
| Investing Cash Flow | -74.53 Million | -40.96 Million | -17.39 Million | -13.19 Million | -1.89 Million | 46.65 Million |
| Investments in PPE | -68.29 Million | -34.09 Million | -11.67 Million | -8.63 Million | -30.84 Million | -31.3 Million |
| Acquisitions | -499 Thousand | -857 Thousand | - | -107 Thousand | 32.65 Million | 2.31 Million |
| Investment purchases | - | - | - | -2.63 Million | - | -101 Thousand |
| Sales/Maturities of investments | - | - | 1.09 Million | 163 Thousand | 2.3 Million | 72.12 Million |
| Other Investing Activities | -5.73 Million | -6.01 Million | -6.82 Million | -1.97 Million | -3.71 Million | 3.61 Million |
| Financing Cash Flow | -25.63 Million | -55.53 Million | -25.85 Million | -1.08 Million | -19.56 Million | -26.41 Million |
| Debt repayment | -14 Million | -35.97 Million | -60.01 Million | -37.54 Million | -53.17 Million | -29.95 Million |
| Dividends payments | -35 Million | -35 Million | - | - | - | - |
| Common Stock Repurchased | -9.87 Million | - | - | -213 Thousand | -14.43 Million | -4.69 Million |
| Common Stock Issuance | 2.07 Million | 6.08 Million | 110 Thousand | - | - | - |
| Other Financing Activities | 31.17 Million | 9.35 Million | 34.05 Million | 36.68 Million | 48.04 Million | 8.23 Million |
| Accounts receivables | 12.05 Million | -18.98 Million | -51.15 Million | 49.81 Million | -24.74 Million | -39.18 Million |
| Accounts payables | - | 18.98 Million | 51.15 Million | -49.81 Million | 24.74 Million | - |
| Inventory | 851 Thousand | -278 Thousand | 2.9 Million | -6.19 Million | -11.45 Million | 8.63 Million |
| Other working capital | 6.19 Million | -7.2 Million | -27.63 Million | 31.07 Million | -16.74 Million | -37.95 Million |
| Cash at beginning of period | 118.52 Million | 97.72 Million | 43.86 Million | 78.21 Million | 62.98 Million | 37.78 Million |
| Cash at end of period | 51.62 Million | 118.52 Million | 97.72 Million | 43.86 Million | 78.21 Million | 62.98 Million |
| Capital Expenditure | -68.29 Million | -34.09 Million | -11.67 Million | -8.63 Million | -30.84 Million | -31.3 Million |
| Effect of forex changes on cash | -1.97 Million | -2.18 Million | -1.01 Million | 86 Thousand | 1000.00 | -142 Thousand |
| Net cash flow / Change in cash | -66.9 Million | 20.8 Million | 53.85 Million | -34.35 Million | 15.23 Million | 25.2 Million |
| Free Cash Flow | -33.06 Million | 85.4 Million | 86.45 Million | -28.8 Million | 5.84 Million | -26.19 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.67 Million | 3.67 Million | -9.97 Million | 16.56 Million | -9.97 Million | 4.92 Million |
| Depreciation & Amortization | 9.54 Million | 9.54 Million | 7.64 Million | 36.93 Million | 4.99 Million | 10.82 Million |
| Deferred income taxes | - | - | - | -26.22 Million | - | 9.05 Million |
| Stock-based compensation | 42.5 Thousand | 42.5 Thousand | 29 Thousand | 96 Thousand | 29 Thousand | 19 Thousand |
| Change in working capital | -21.83 Million | -21.83 Million | 12.69 Million | 7.04 Million | 12.69 Million | -11.71 Million |
| Other non-cash items | 5.47 Million | 5.47 Million | -4.54 Million | 818 Thousand | -1.9 Million | 7.7 Million |
| Investing Cash Flow | -17.93 Million | -17.93 Million | -24.62 Million | -74.53 Million | -24.62 Million | -12.64 Million |
| Investments in PPE | -13.76 Million | -13.76 Million | -20.92 Million | -68.29 Million | -20.92 Million | -8.04 Million |
| Acquisitions | - | - | - | -499 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -4.17 Million | -4.17 Million | -3.7 Million | -5.73 Million | -3.7 Million | -4.59 Million |
| Financing Cash Flow | 6.5 Million | 6.5 Million | 306.5 Thousand | -25.63 Million | 306.5 Thousand | -13.12 Million |
| Debt repayment | - | - | - | -14 Million | - | - |
| Dividends payments | -5 Million | -5 Million | - | -35 Million | - | -17.5 Million |
| Common Stock Repurchased | - | - | -4.77 Million | -9.87 Million | -4.77 Million | -164 Thousand |
| Common Stock Issuance | - | - | - | 2.07 Million | - | - |
| Other Financing Activities | 11.5 Million | 11.5 Million | 5.07 Million | 31.17 Million | 5.07 Million | 4.54 Million |
| Accounts receivables | -15.61 Million | -15.61 Million | 13.52 Million | 12.05 Million | 13.52 Million | -7.5 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -6.2 Million | -6.2 Million | 2 Million | 851 Thousand | 2 Million | -1.57 Million |
| Other working capital | -9000.00 | -9000.00 | -2.83 Million | 6.19 Million | -2.83 Million | -2.63 Million |
| Cash at beginning of period | - | - | - | 118.52 Million | - | - |
| Cash at end of period | -14.66 Million | -14.66 Million | -19.64 Million | 51.62 Million | -19.64 Million | -13.8 Million |
| Capital Expenditure | -13.76 Million | -13.76 Million | -20.92 Million | -68.29 Million | -20.92 Million | -8.04 Million |
| Effect of forex changes on cash | -134.5 Thousand | -134.5 Thousand | -1.17 Million | -1.97 Million | -1.17 Million | 185 Thousand |
| Net cash flow / Change in cash | -14.66 Million | -14.66 Million | -19.64 Million | -66.9 Million | -19.64 Million | -13.8 Million |
| Free Cash Flow | -16.86 Million | -16.86 Million | -15.07 Million | -33.06 Million | -15.07 Million | 3.72 Million |
2125
1NBA
AXCP
DRMA
6349
JOHNPHARMA